Your browser doesn't support javascript.
loading
Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience.
Sawas, Ahmed; Ma, Helen; Kuruvilla, John; Lue, Jennifer K; Deng, Changchun; Marchi, Enrica; Montanari, Francesca; Cheng, Bin; Savage, Kerry J; Villa, Diego; Crump, Michael; Connors, Joseph M; O'Connor, Owen A.
Afiliación
  • Sawas A; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY, USA.
  • Ma H; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY, USA.
  • Kuruvilla J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Lue JK; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY, USA.
  • Deng C; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY, USA.
  • Marchi E; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY, USA.
  • Montanari F; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY, USA.
  • Cheng B; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY, USA.
  • Savage KJ; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Villa D; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Crump M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Connors JM; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • O'Connor OA; Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA.
Leuk Lymphoma ; 61(12): 3014-3017, 2020 12.
Article en En | MEDLINE | ID: mdl-32720828

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article